Status:

ACTIVE_NOT_RECRUITING

Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions

Lead Sponsor:

University of Luebeck

Conditions:

Evaluation of New Tissue Biomarkers for Cervical Cancer

Eligibility:

FEMALE

Brief Summary

The following trial is a multicenter and prospective research trial of the colposcopy unit of luebeck university and the national research center in Borstel, Germany. The study is to identify and eva...

Eligibility Criteria

Inclusion

  • Positive informed consent
  • Patients with suspected preinvasive genital lesion
  • Patients with confirmed genital lesion (both preinvasive and invasive)
  • Contact via dept. of obs/gyn of luebeck university
  • Complete set of data

Exclusion

  • Incomplete set of data
  • Negative informed consent

Key Trial Info

Start Date :

September 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT02238990

Start Date

September 1 2014

End Date

December 1 2030

Last Update

May 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Luebeck University, Department for obstetrics and gynecology

Lübeck, Schleswig-Holstein, Germany, D-23538

Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions | DecenTrialz